But here's the thing. . . "Trials start "soon" for the new CNS product.". . . -Do they really? What is meant by "soon"? Every conference call has vague upbeat speculation that does not come to fruition. -We were told there would be no hold-up with API. Now we hear we are yet again waiting for API.